Which hedge funds own 430? TERNS PHARMACEUTICALS INC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in 430 (TERNS PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $0 in total. 94 exited: Beryl Capital Management LLC, KVP Capital Advisors, LP, NEXTBio Capital Management LP.
- 0
- Holders
- 0
- New this quarter
- 94
- Exited this quarter
- $0
- Combined value
- 0.0%
- Share of managers holding
Holders, Q2 2026
Exited since the previous filing
Held in a manager's last filing
| CIBRA Capital Ltd | Q1 2026 | Q2 2026 filing not yet received | 3.9% |
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q2 2026 | 0 | 1,205 | 0.0% | $0 |
| Q1 2026coverage widened | 95 | 1,209 | 7.9% | $2.8bn |
| Q4 2025 | 6 | 71 | 8.5% | $239m |
| Q3 2025 | 2 | 73 | 2.7% | $7.3m |
| Q2 2025 | 2 | 73 | 2.7% | $4.6m |
| Q1 2025 | 3 | 73 | 4.1% | $5.2m |
| Q4 2024 | 3 | 74 | 4.1% | $12.1m |
| Q3 2024 | 5 | 73 | 6.8% | $47.0m |
| Q2 2024 | 4 | 73 | 5.5% | $24.1m |
| Q1 2024 | 2 | 73 | 2.7% | $23.5m |
| Q4 2023 | 1 | 73 | 1.4% | $37.9m |
| Q3 2023 | 3 | 73 | 4.1% | $34.7m |
| Q2 2023 | 2 | 73 | 2.7% | $49.1m |
| Q1 2023 | 3 | 73 | 4.1% | $49.5m |
| Q4 2022 | 3 | 73 | 4.1% | $38.7m |
| Q3 2022 | 1 | 74 | 1.4% | $896k |
| Q2 2022 | 4 | 74 | 5.4% | $7.9m |
| Q1 2022 | 3 | 74 | 4.1% | $4.2m |
| Q4 2021 | 1 | 74 | 1.4% | $8.8m |
| Q3 2021 | 1 | 71 | 1.4% | $11.7m |
| Q2 2021 | 1 | 71 | 1.4% | $13.8m |
| Q1 2021 | 2 | 70 | 2.9% | $33.6m |
Who discovered 430 first?
Earliest meaningful positions among the 11 tracked managers seen opening 430 since Q1 2021.
| Montanova Capital, LLC | Q1 2021 | 0.4% | Exited by Q2 2024 | −70% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.
89 already held it when coverage began
Adage Capital Partners GP, L.L.C. (Q1 2026), ADAR1 Capital Management, LLC (Q1 2026), Affinity Asset Advisors, LLC (Q1 2026), Alpine Associates Management Inc. (Q1 2026), Alyeska Investment Group, L.P. (Q1 2026), AQR Arbitrage LLC (Q1 2026), AQR Capital Management LLC (Q1 2026), Arnhold LLC (Q1 2026), Artia Global Partners LP (Q1 2026), Atika Capital Management LLC (Q1 2026), Avoro Capital Advisors LLC (Q1 2026), Balyasny Asset Management L.P. (Q1 2026), Beryl Capital Management LLC (Q1 2026), Boothbay Fund Management, LLC (Q1 2026), Boxer Capital Management, LLC (Q1 2026), Brevan Howard Capital Management LP (Q1 2026), Burkehill Global Management, LP (Q1 2026), Candriam S.C.A. (Q1 2026), Cannon Global Investment Management, LLC (Q1 2026), Carlson Capital, L.P. (Q1 2026), Catalio Capital Management, LP (Q1 2026), Caxton Associates LLP (Q1 2026), Centiva Capital, LP (Q1 2026), Chicago Capital Management, LLC (Q1 2026), CIBRA Capital Ltd (Q1 2026), Cinctive Capital Management LP (Q1 2026), Citadel Advisors LLC (Q1 2026), Cormorant Asset Management, LP (Q1 2026), D. E. Shaw & Co., Inc. (Q1 2026), Dark Forest Capital Management LP (Q1 2026), Davidson Kempner Capital Management LP (Q1 2026), Deep Track Capital, LP (Q1 2026), Diadema Partners LP (Q1 2026), DLD Asset Management, LP (Q1 2026), Eagle Health Investments LP (Q1 2026), Engineers Gate Manager LP (Q1 2026), ExodusPoint Capital Management, LP (Q1 2026), Fifth Lane Capital, LP (Q1 2026), FNY Investment Advisers, LLC (Q1 2026), FORA Capital, LLC (Q1 2026), Fort Baker Capital Management LP (Q1 2026), Fortress Investment Group LLC (Q1 2026), GABELLI & Co INVESTMENT ADVISERS, INC. (Q1 2026), Glazer Capital, LLC (Q1 2026), HBK Investments L P (Q1 2026), HighVista Strategies LLC (Q1 2026), Hudson Bay Capital Management LP (Q1 2026), Ikarian Capital, LLC (Q1 2026), J. Goldman & Co LP (Q1 2026), Jain Global LLC (Q1 2026), Jones Hill Capital LP (Q1 2026), Kintayl Capital LP (Q1 2026), KVP Capital Advisors, LP (Q1 2026), Landscape Capital Management, L.L.C. (Q1 2026), Lighthouse Investment Partners, LLC (Q1 2026), Logos Global Management LP (Q1 2026), Magnetar Financial LLC (Q1 2026), Marshall Wace, LLP (Q1 2026), Meteora Capital, LLC (Q1 2026), Millennium Management LLC (Q1 2026), MYDA Advisors LLC (Q1 2026), NEXTBio Capital Management LP (Q1 2026), Octagon Capital Advisors LP (Q1 2026), Oxford Asset Management LLP (Q1 2026), Paradigm Biocapital Advisors LP (Q1 2026), Persistent Asset Partners Ltd (Q1 2026), PFM Health Sciences, LP (Q1 2026), Polar Asset Management Partners Inc. (Q1 2026), Prelude Capital Management, LLC (Q1 2026), Prosight Management, LP (Q1 2026), Quantbot Technologies LP (Q1 2026), Qube Research & Technologies Ltd (Q1 2026), Rock Springs Capital Management LP (Q1 2026), Samlyn Capital, LLC (Q1 2026), Sand Grove Capital Management LLP (Q1 2026), Schonfeld Strategic Advisors LLC (Q1 2026), Sculptor Capital LP (Q1 2026), Sio Capital Management, LLC (Q1 2026), Slotnik Capital, LLC (Q1 2026), Squarepoint Ops LLC (Q1 2026), SummitTX Capital, L.P. (Q1 2026), TIG Advisors, LLC (Q1 2026), Twin Securities, Inc. (Q1 2026), Two Sigma Investments, LP (Q1 2026), Vazirani Asset Management LLC (Q1 2026), Verdad Advisers, LP (Q1 2026), Verition Fund Management LLC (Q1 2026), Vestal Point Capital, LP (Q1 2026), Whitebox Advisors LLC (Q1 2026)